Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 4:2018:4757893.
doi: 10.1155/2018/4757893. eCollection 2018.

Honey and Diabetes: The Importance of Natural Simple Sugars in Diet for Preventing and Treating Different Type of Diabetes

Affiliations
Review

Honey and Diabetes: The Importance of Natural Simple Sugars in Diet for Preventing and Treating Different Type of Diabetes

Otilia Bobiş et al. Oxid Med Cell Longev. .

Abstract

Diabetes is a metabolic disorder with multifactorial and heterogeneous etiologies. Two types of diabetes are common among humans: type 1 diabetes that occurs when the immune system attacks and destroys insulin and type 2 diabetes, the most common form, that may be caused by several factors, the most important being lifestyle, but also may be determined by different genes. Honey was used in folk medicine for a long time, but the health benefits were explained in the last decades, when the scientific world was concerned in testing and thus explaining the benefits of honey. Different studies demonstrate the hypoglycemic effect of honey, but the mechanism of this effect remains unclear. This review presents the experimental studies completed in the recent years, which support honey as a novel antidiabetic agent that might be of potential significance for the management of diabetes and its complications and also highlights the potential impacts and future perspectives on the use of honey as an antidiabetic agent.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Shaw J. E., Sicree R. A., Zimmet P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetic Research and Clinical Practice. 2010;87(1):4–14. doi: 10.1016/j.diabres.2009.10.007. - DOI - PubMed
    1. Wei M., Gaskill S. P., Haffner S. M., Stern M. P. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: the San Antonio Heart Study. Diabetes Care. 1998;21(7):1167–1172. doi: 10.2337/diacare.21.7.1167. - DOI - PubMed
    1. Barr E. L. M., Zimmet P. Z., Welborn T. A., et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose and impaired glucose tolerance. the Australian Diabetes, Obesity and Lifestyle Study. Circulation. 2007;116(2):151–157. doi: 10.1161/CIRCULATIONAHA.106.685628. - DOI - PubMed
    1. Kokil G. R., Rewatkar P. V., Verma A., Thareja S., Naik S. R. Pharmacology and chemistry of diabetes mellitus and antidiabetic drugs: a critical review. Current Medicinal Chemistry. 2010;17(35):4405–4423. doi: 10.2174/092986710793361225. - DOI - PubMed
    1. Roglic G., Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetic Research and Clinical Practice. 2010;87(1):15–19. doi: 10.1016/j.diabres.2009.10.006. - DOI - PubMed